| scholarly article | Q13442814 |
| P50 | author | Nilesh Samani | Q19665717 |
| Wolfgang Koenig | Q20172819 | ||
| Naveed Sattar | Q37378984 | ||
| Mika Kivimäki | Q37386335 | ||
| Patrik K E Magnusson | Q37389903 | ||
| Meena Kumari | Q37390225 | ||
| Yvonne T van der Schouw | Q37390536 | ||
| Sander W van der Laan | Q37625254 | ||
| Annette Peters | Q37629853 | ||
| Janine F Felix | Q38359239 | ||
| Johan Ärnlöv | Q38620593 | ||
| Lambertus Kiemeney | Q40024880 | ||
| Folkert Asselbergs | Q42391830 | ||
| Christopher J O'Donnell | Q89928448 | ||
| Jens Baumert | Q91119753 | ||
| Sanaz Sedaghat | Q98906261 | ||
| Riyaz Patel | Q101382845 | ||
| Vinicius Tragante | Q46003855 | ||
| Aroon Hingorani | Q47156734 | ||
| Delilah Zabaneh | Q47502416 | ||
| Alanna Morrison | Q55856687 | ||
| Rainer Malik | Q56528757 | ||
| Oscar H Franco | Q56839732 | ||
| Marcus Dörr | Q56840322 | ||
| Per Svensson | Q57078401 | ||
| Hester den Ruijter | Q57294289 | ||
| Gerard Pasterkamp | Q57298458 | ||
| Stella Trompet | Q28516585 | ||
| Abbas Dehghan | Q29839252 | ||
| Michael V Holmes | Q57557202 | ||
| Tove Fall | Q57641991 | ||
| Anders Larsson | Q59163549 | ||
| Nancy Pedersen | Q60984270 | ||
| Christopher P Nelson | Q61196164 | ||
| J Wouter Jukema | Q64858750 | ||
| Lars Lind | Q65992534 | ||
| N Charlotte Onland-Moret | Q67212585 | ||
| Joshua C Bis | Q79326643 | ||
| Fotios Drenos | Q79846322 | ||
| Maryam Kavousi | Q82821617 | ||
| Andrew P Morris | Q85050906 | ||
| Paul I W de Bakker | Q85643659 | ||
| Tom Wilsgaard | Q86476613 | ||
| Brendan J Keating | Q87598821 | ||
| Nora Franceschini | Q88050391 | ||
| Sebastian E Baumeister | Q88187003 | ||
| Patricia B Munroe | Q88350963 | ||
| P2093 | author name string | Alex P Reiner | |
| Tessel E Galesloot | |||
| Bradford B Worrall | |||
| Stéphanie Debette | |||
| Jacqueline de Graaf | |||
| Ivana Isgum | |||
| Bjørn Odvar Eriksen | |||
| Ingrid Toft | |||
| Aicha Soumaré | |||
| Johannes Arpegård | |||
| P2860 | cites work | A genome-wide association for kidney function and endocrine-related traits in the NHLBI's Framingham Heart Study | Q21261435 |
| Cystatin C deficiency in human atherosclerosis and aortic aneurysms | Q22010733 | ||
| ‘Mendelian randomization’: can genetic epidemiology contribute to understanding environmental determinants of disease?* | Q22066036 | ||
| Genetic studies of body mass index yield new insights for obesity biology | Q22305005 | ||
| Meta-analysis and imputation refines the association of 15q25 with smoking quantity | Q24273244 | ||
| Clinical correlates and heritability of cystatin C (from the Framingham Offspring Study) | Q37259589 | ||
| Interpretation of tests of heterogeneity and bias in meta-analysis | Q37329334 | ||
| Cystatin C versus creatinine in determining risk based on kidney function | Q37712784 | ||
| Contribution of 30 biomarkers to 10-year cardiovascular risk estimation in 2 population cohorts: the MONICA, risk, genetics, archiving, and monograph (MORGAM) biomarker project | Q38416428 | ||
| Cystatin C and the risk for cardiovascular events in patients with asymptomatic carotid atherosclerosis | Q39901357 | ||
| Sample size and power calculations in Mendelian randomization with a single instrumental variable and a binary outcome | Q40533832 | ||
| Serum lipid levels, body mass index, and their role in coronary artery calcification: a polygenic analysis | Q41596376 | ||
| Cystatin C is independently associated with total and cardiovascular mortality in individuals undergoing coronary angiography. The Ludwigshafen Risk and Cardiovascular Health (LURIC) study | Q44300324 | ||
| Serum cystatin C and increased coronary heart disease prevalence in US adults without chronic kidney disease | Q45155775 | ||
| Cystatin C and cardiovascular mortality in patients with coronary artery disease and normal or mildly reduced kidney function: results from the AtheroGene study | Q46157359 | ||
| Evidence of linkage and association on chromosome 20 for late-onset Alzheimer disease | Q47912645 | ||
| Loci influencing blood pressure identified using a cardiovascular gene-centric array. | Q55415905 | ||
| Mendelian randomization: Using genes as instruments for making causal inferences in epidemiology | Q57108274 | ||
| Cystatin C modulates cerebral beta-amyloidosis | Q24300978 | ||
| Genome-wide meta-analyses identify multiple loci associated with smoking behavior | Q24597886 | ||
| Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis | Q24609915 | ||
| New loci associated with kidney function and chronic kidney disease | Q24630646 | ||
| Association of cystatin C with mortality, cardiovascular events, and incident heart failure among persons with coronary heart disease: data from the Heart and Soul Study | Q24646339 | ||
| Measuring inconsistency in meta-analyses | Q27860655 | ||
| Cystatin C and the risk of death and cardiovascular events among elderly persons | Q28251528 | ||
| New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk | Q28270700 | ||
| The Genotype-Tissue Expression (GTEx) project | Q28657968 | ||
| Discovery and refinement of loci associated with lipid levels | Q28661470 | ||
| Genetics and beyond--the transcriptome of human monocytes and disease susceptibility | Q28752094 | ||
| Multiple loci associated with indices of renal function and chronic kidney disease | Q28943262 | ||
| Association of genome-wide variation with the risk of incident heart failure in adults of European and African ancestry: a prospective meta-analysis from the cohorts for heart and aging research in genomic epidemiology (CHARGE) consortium | Q28943463 | ||
| Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease | Q29417023 | ||
| Genetic risk factors for ischaemic stroke and its subtypes (the METASTROKE collaboration): a meta-analysis of genome-wide association studies | Q29417025 | ||
| A genome-wide association study in Europeans and South Asians identifies five new loci for coronary artery disease | Q29417111 | ||
| Genetic loci influencing kidney function and chronic kidney disease | Q34109552 | ||
| Common variants at 10 genomic loci influence hemoglobin A₁(C) levels via glycemic and nonglycemic pathways | Q34355379 | ||
| A genome-wide association study of circulating galectin-3 | Q34443077 | ||
| Novel and conventional biomarkers for prediction of incident cardiovascular events in the community | Q34960396 | ||
| Comparison of heritability of Cystatin C- and creatinine-based estimates of kidney function and their relation to heritability of cardiovascular disease | Q35088150 | ||
| New genetic loci link adipose and insulin biology to body fat distribution | Q35114362 | ||
| Cystatin C Is Not Causally Related to Coronary Artery Disease | Q35658295 | ||
| Meta-analysis of genome-wide association studies from the CHARGE consortium identifies common variants associated with carotid intima media thickness and plaque | Q35670591 | ||
| Population-specific coding variant underlies genome-wide association with adiponectin level | Q35747135 | ||
| A cross-platform analysis of 14,177 expression quantitative trait loci derived from lymphoblastoid cell lines | Q36732476 | ||
| Loci influencing blood pressure identified using a cardiovascular gene-centric array | Q36853815 | ||
| Mapping cis- and trans-regulatory effects across multiple tissues in twins | Q37200482 | ||
| Cystatin C, associated with hemorrhagic and ischemic stroke, is a strong predictor of the risk of cardiovascular events and death in Chinese | Q81464141 | ||
| P4510 | describes a project that uses | RStudio | Q4798119 |
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cardiovascular disease | Q389735 |
| P304 | page(s) | 934-945 | |
| P577 | publication date | 2016-08-01 | |
| P1433 | published in | Journal of the American College of Cardiology | Q2984355 |
| P1476 | title | Cystatin C and Cardiovascular Disease: A Mendelian Randomization Study | |
| P478 | volume | 68 |
| Q91976118 | Association of Cystatin C with Metabolic Syndrome and Its Prognostic Performance in Non-ST-Segment Elevation Acute Coronary Syndrome with Preserved Renal Function |
| Q55400363 | Can cystatin C-based estimated glomerular filtration rate help to guide individualized risk factor modification programs? |
| Q64911301 | Cardiovascular Risk in Type 1 Diabetes Mellitus. |
| Q55030557 | Common Methods for Performing Mendelian Randomization. |
| Q59796621 | Cystatin C as a Candidate Biomarker of Cardiovascular Outcomes: Too Near, but too Far from Reality |
| Q58121766 | Cystatin C for Risk Stratification in Patients After an Acute Coronary Syndrome |
| Q42688068 | Factors associated with high brachial-ankle pulse wave velocity in non-hypertensive and appropriately treated hypertensive patients with atherosclerotic risk factors |
| Q38651014 | Lack of association between cystatin C and different coronary atherosclerotic manifestations. |
| Q50109537 | Letter to the Editor regarding the article 'Left atrial volume index in patients with heart failure and severely impaired left ventricular systolic function: the role of established echocardiographic parameters, circulating cystatin C and galectin-3 |
| Q93164255 | Multilevel omics for the discovery of biomarkers and therapeutic targets for stroke |
| Q91629328 | Serum Cystatin C and Arterial Stiffness in Middle-Aged and Elderly Adults without Chronic Kidney Disease: A Population-Based Study |
| Q64111361 | Stroke genetics: discovery, biology, and clinical applications |
| Q61454580 | Value of cystatin C in predicting atrial fibrillation recurrence after radiofrequency catheter ablation |
Search more.